The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage

Journal of Nuclear Medicine

Volumn 44, Issue 9, 2003, Pages 1531-1539

  Goethals, Ingeborg ^a   Dierckx, Rudi ^a   De Meerleer, Gert ^a   De Sutter, Johan ^a   De Winter, Olivier ^a   De Neve, Wilfried ^a   Van De Wiele, Christophe ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Adverse effects; Monitoring; Nuclear medicine; Prediction; Thoracic radiotherapy

Indexed keywords

CARDIOMYOPATHY; DIAGNOSTIC PROCEDURE; FIBROSIS; HEART INJURY; HUMAN; IMAGING; IRRADIATION; LUNG INJURY; MOLECULAR BIOLOGY; NUCLEAR MEDICINE; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BREAST TUMOR; COMPUTER ASSISTED RADIOTHERAPY; HEART; HODGKIN DISEASE; LUNG; LYMPHOMA; METHODOLOGY; MORTALITY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PNEUMONIA; RADIATION PROTECTION; RADIATION RESPONSE; RADIOMETRY; RADIOTHERAPY; RISK ASSESSMENT; SCINTISCANNING;

BREAST NEOPLASMS; CARDIOMYOPATHIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEART; HODGKIN DISEASE; HUMANS; LUNG; LYMPHOMA; RADIATION INJURIES; RADIATION PNEUMONITIS; RADIATION PROTECTION; RADIOMETRY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RISK ASSESSMENT;

EID: 0142181253     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Nakayama Y, Makino S, Fukuda Y, Min KY, Shimizu A, Ohsawa N. Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 1996;34:459-467
2. Abratt R, Morgan G. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer. 2002;35:103-109.
3. Rubin P, Finkelstein J, Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast Int J Radiat Oncol Biol Phys. 1992;24:93-101.
4. Seppenwoolde Y, Lebesque J. Partial irradiation of the lung. Semin Radiat Oncol. 2001;11:247-258.
5. Boersma L, Damen E, de Boer R, et al. Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. J Clin Oncol. 1996;14:1431-1441.
6. Bjermer L, Franzen L, Littbrand B, Nilsson K, Angstrom T, Hennksson R. Effects of smoking and irradiated volume on inflammatory response in the lung of irradiated breast cancer patients evaluated with bronchoalveolar lavage. Cancer Res. 1990;50:2027-2030.
7. Marks L, Munley M, Bentel G, et al Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys. 1997;39:563-570.
8. Kutcher G, Burman C, Brewster M, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys. 1991;21:137-146.
9. Niemierko A, Goitein M. Modelling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys. 1992;25:135-145
10. Theuws J, Seppenwoolde Y, Kwa S, et al. Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys. 2000;47:1201-1208
11. Bna WF, Kanarek DJ, Kazemi H. Prediction of postoperative pulmonary function following thoracic operations, value of ventilation-perfusion scanning. J Thorac Cardiovasc Surg 1983;86:186-192
12. Boysen PG. Pulmonary resection and postoperative pulmonary function. Chest. 1980;77:718-719.
13. Rubenstein J, Richter M, Moldofsky P, Sohn L. Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing Int J Radiat Oncol Biol Phys. 1988;15:83-87.
14. Choi N, Kanarek D, Grillo H, Effect of post-operative radiotherapy on changes in pulmonary function in patients with stage II and IIIa lung carcinoma. Int J Radiat Oncol Biol Phys. 1990;18:95-99.
15. Curran W, Moldofsky P, Solin L. Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int J Radiat Oncol Biol Phys. 1992;24:31-36.
16. Boersma L, Damen E, de Boer R, et al. A new method to determine dose-effect relations for local lung function changes using correlated SPECT and CT data. Radiother Oncol. 1993;29:110-116.
17. Boersma L, Damen E, de Boer R, et al. Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. Radiother Oncol. 1994;32:201-209
18. Boersma LJ, Damen EM, de Boer RW, et al. Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury, Radiother Oncol. 1995;36:15-23.
19. Theuws J, Kwa S, Wagenaar A, et al Prediction of overall pulmonary function loss in relation to 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol. 1998;49:233-243
20. Levinson B, Marks L, Munley M, et al. Regional dose response to pulmonary irradiation using a manual method. Radiother Oncol. 1998;48:53-60.
21. Seppenwoolde Y, Muller S, Theuws J, et al. Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2000;47:681-690.
22. Rotstein S, Lax I, Svane G Influence of radiation therapy on the lung tissue in breast cancer patients: CT-assessed density changes and associated symptoms. Int J Radiat Oncol Biol Phys. 1990;18:173-180.
23. Abratt R, Willcox P, Smith J. Lung cancer in patients with borderline lung functions: zonal lung function scans at presentation and lung function after high dose irradiation. Radiother Oncol. 1990;19:317-322
24. Choi N, Kanarek D. Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer. 1994, 10(suppl I):S219-S230.
25. Cattaneo G, Rizzo G, Lombardi P, et al. Integration of computerized tomography imaging with single photon emission in a commercial system for developing radiotherapy fields: application to conformational irradiation for lung carcinoma. Radiol Med (Torino). 1999;97:272-278.
26. Marks L, Spencer D, Sherouse G. et al. The role of three dimensional functional lung imaging in radiation treatment planning the functional dose-volume histogram. Int J Radiat Oncol Biol Phys. 1995;33:65-75.
27. Marks L, Spencer D, Bentel G, et al. The utility of SPECT lung perfusion scans in minimizing and assessing physiologic consequences of thoracic irradiation. Int J Radiat Oncol Biol Phys. 1993;26:659-668.
28. Munley M, Marks L, Scarfone C, et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer. 1999;23:105-114
29. McDonald S, Rubin P, Phillips T, Marks L. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints and potential scoring systems. Int J Radiat Oncol Biol Phys. 1995;31:1187-1203.
30. Roswit B, White D. Severe radiation injuries of the lung. AJR. 1977;129:127-136.
31. Libshitz H. Radiation changes in the lung. Semin Roentgenol 1993;28:303-320.
32. Kataoka M, Kawamura M, Itoh H, Hamamoto K Gallium-67 citrate scintigraphy for the early detection of radiation pneumonitis Clin Nucl Med 1992;17:27-31
33. Bell J, McGivern D, Bullimore J, Hill J, Davies E, Goddard P. Diagnostic imaging of postirradiation changes in the chest. Clin Radiol. 1988;39:109-119.
34. Prato F, Kurdyak R, Saibil E, Rider W, Aspin N. Physiological and radiographic assessment during development of pulmonary radiation fibrosis. Radiology. 1977; 122:389-397.
35. Ishii Y, Kitamura S. Soluble intercellular adhesion molecule-1 as an early detection marker for radiation pneumonitis. Eur Respir J. 1999;13:733-738.
36. Ikezoe J, Takashima S, Morimoto S, et al. CT appearance of acute radiation-induced injury in the lung. AJR 1988;150:765-770
37. Roberts C, Foulcher E, Zaunders J, et al Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction Ann intern Med. 1993;118:696-700
38. Henschke C, Davis S, Yankelewitz D, et al Imaging of lung injury due to radiation. Appl Radiol. 1993;22:42-46
39. Skopek J, Kolesnikov-Gauthier H, Wirquin V, et al. Experimental radiation pneumonitis studied with indium-111 pentetreotide. Cancer Biother Radiopharm. 2000;15:30-37.
40. Valdés Olmos R, van Zandwijk N, Boersma L, et al. Radiation pneumonitis imaged with indium-111-pentetreotide. J Nucl Med. 1996;37:584-588.
41. Stoffel M, Jamar F, Donckier J, et al. increased uptake of indium-111 pentetreotide up to 10 years after external thoracic irradiation: report of two cases. Eur J Nucl Med. 1996;23:723-726
42. Susskind H, Weber D, Lau Y, et al Impaired permeability in radiation-induced lung injury detected by technetium-99m DTPA lung clearance. J Nucl Med. 1997;38:966-971.
43. Groth S, Johansen H, Sorensen P, Rossing N The effect of thoracic irradiation for cancer of the breast on ventilation, perfusion and pulmonary permeability. Acta Oncol 1989;28:671-677.
44. 99mTc-DTPA aerosol inhalation method. Jap J Thorac Dis. 1993;31:199-205.
45. Ling L, Oh J, Schaff H, et al. Constructive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100:1380-1386.
46. Valdés Olmos R, Hoefnagel C, van der School J. Nuclear medicine in the monitoring of organ function and the detection of injury related to cancer therapy. Eur J Nucl Med. 1993;20:515-546.
47. Corn BW, Trock BJ, Goodman RL. Irradiation-related ischemic heart disease. J Clin Ontol. 1990;8:741-750.
48. Lipshultz S, Sallan E. Cardiovascular abnormalities in long-term survivors of childhood malignancy. J Clin Oncol. 1993;11:1199-1203.
49. Cosset J-M, Henry-Amar M, Pellae-Cosset B, et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int J Radiat Oncol Biol Phys. 1991;21:447-449.
50. Carlson R, Mayfield W, Normann S, Alexander A. Radiation-associated valvular disease. Chest. 1991;99:538-545.
51. Pahjola-Sintonen S, Totterman K, Kupari M. Sick sinus syndrome as a complication of mediastinal radiation therapy. Cancer. 1990;65:2494-2496.
52. Tarbell N, Mauch P. Thoracic irradiation in Hodgkin's disease: disease-control and long-term complications. Int J Radiat Oncol Biol Phys. 1990;18:275-281.
53. Boivin J, Hutchinson G, Lubin J, Mauch P Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 1992;69:1241-1247
54. Constine L, Schwanz R, Savage D, King V, Muhs A. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1997;39:897-906.
55. Rutqvist L, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992;22:887-896.
56. Hancock S, Tucker M, Hoppe R Factors affecting late mortality from heart disease after treatment of Hodgkin's disease JAMA. 1993;270:1949-1955.
57. Hancock S, Hoppe R. Late-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol 1996;6:225-242.
58. Stewart J, Fajardo L. Radiation-induced heart disease: an update. Prog Cardiovasc Dis. 1984;27:173-194
59. Jones J, Ribeiro G. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol. 1989;40:204-208.
60. Hancock S, Donaldson S, Hoppe R. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol. 1993;11:1208-1215
61. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy J Clin Oncol 1994;12:447-453
62. Glanzmann C, Huguenm P, Lutolf U, Maire R, Jenm R, Gumppenherg V. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother Oncol. 1994;30:43-54.
63. Morgan G, Freeman A, McLean R, Jarvie B, Giles R. Late cardiac, thyroid and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease Int J Radiat Oncol Biol Phys. 1985;11:1925-1931.
64. Savage D, Constine L, Schwanz R, Rubin P. Radiation effects on left ventricular function and myocardial perfusion in long-term survivors of Hodgkin's disease Int J Radiat Oncol Biol Phys. 1990;19:721-727.
65. Girinsky T, Cordova A, Rey A, Cosset J-M, Tertian G, Pierga J-Y. Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal radiation. Int J Radiat Oncol Biol Phys. 2000;48:1503-1506.
66. Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist L. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy, a prospective study. Int J Radiat Oncol Biol Phys. 1996;36:899-905.
67. Cowen D, Gonzague-Casabianca L, Brenot-Rossi I, et al. Thallium-201 perfusion scintigraphy in the evaluation of late myocardial damage in left-side breast cancer treated with adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:809-815.
68. Gustavsson A, Bendahl P-O, Cwikrel M, Eskilsson J, Thapper K, Pahlm O. No serious late cardiac effects after adjuvant radiotherapy following mastectomy in premenopausal women with early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:745-754.
69. Hardenbergh PH, Munley MT, Bentel GC, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 2001;49:1023-1028.
70. 111In-Antimyosin myocardial scintigraphy in patients undergoing mediastinum or whole body irradiation [abstract]. Eur J Nucl Med 1992;19:672.
71. Gustavsson A, Eskilsson J, Landberg T, Svahn-Tapper G, White T, Wollmer P. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol. 1990;1:355-363.
72. Maunoury C, Pierga J-Y, Valette H, Tchernia G, Cosset J-M, Desgrez A. Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study Eur J Nucl Med. 1992;19:871-873.
73. Pierga J-Y, Maunoury C, Valette H, et al. Follow-up thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1993;25:871-876
74. Glanzmann C, Kaufmann P, Jenni R, Hess O, Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol. 1998;46:51-62.
75. Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist L. Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy. Eur J Nucl Med 1997;24:286-292.
76. Hojris I, Sand N, Andersen J, Rehling M, Overgaard M. Myocardial perfusion imaging in breast cancer patients with or without post-mastectomy radiotherapy. Radiother Oncol 2000;55:163-172
77. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138-2117.
78. Khaw BA, Gold HK, Yasuda T, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation. 1986;74:501-508.
79. Sisson JC, Shapiro B, Meyers L, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med. 1987;28:1625-1636
80. Valdés Olmos R, ten Bokkel Huinink W, Dewit L, Hoefnagel C, Liem I, van Tinteren H. Iodine-123 metaiodobenzylguanidine in the assessment of late cardiac effects from cancer therapy. Eur J Nucl Med. 1996;23:453-458.
81. Vlachaki M, Ha C, Hagemeister F, et al. Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M D. Anderson Cancer Center 1967-1977. Radiology 1998;208:739-747
82. Lewitt S, Fletcher G. Trials and tribulations: do clinical trials prove that irradiation increases cardiac and secondary cancer mortality in the breast cancer patient? Int J Radiat Oncol Biol Phys 1991;20:523-527.